Skip to content

Helus Pharma Inc.

HELP· Nasdaqxbrl foundCIK 1833141

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -5.54%
Market cap
$457.97M
51.63M shares
Filings
461
CA$0.00
FY 2022−100.0% FY22 yoy
-$148.00M
FY 2026N/M FY26 yoy
—
—
—
-CA$68.93M
FY 2024derivedN/M FY24 yoy
-$4.25
FY 2026N/M FY26 yoy
$157.26M
FY 2026+67.4% FY26 yoy
$457.97M
—
—
2.0×
—
—

FY2026 figures · derived

Price

$8.87+39.36%+$2.50past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

CA$0.00FY 2022
CA$864.00K0FY 2021FY 2022
PeriodEndedValueKindSource trail
FY 20222022-03-31CA$0reported
FY 20212021-03-31CA$864,000reported

Pharmaceutical preparations

Helus Pharma Inc. is the 193rd largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Helus Pharma Inc. · CIK 1833141 · Engraved from SEC EDGAR